In vivo treatment of tyrosinaemia with hypercompact Cas12f1
Main Authors: | Ruochen Guo, Zhifang Li, Guoling Li, Hainan Zhang, Chang Zhang, Xiaona Huo, Xiaoyin Zhang, Xiali Yang, Rongrong Yang, Yuanhua Liu, Xiaozhi Sun, Xinyu Liu, Hui Yang, Yingsi Zhou, Chunlong Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-07-01
|
Series: | Cell Discovery |
Online Access: | https://doi.org/10.1038/s41421-023-00554-y |
Similar Items
-
Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model
by: Zhifang Li, et al.
Published: (2024-01-01) -
Molecular basis for DNA cleavage by the hypercompact Cas12j-SF05
by: Zhiqiang Duan, et al.
Published: (2023-11-01) -
Recommendations for the management of tyrosinaemia type 1
by: de Laet Corinne, et al.
Published: (2013-01-01) -
Hypercompact TnpB and truncated TnpB systems enable efficient genome editing in vitro and in vivo
by: Ming Wang, et al.
Published: (2024-03-01) -
UK Dietary Practices for Tyrosinaemias: Time for Change
by: Anne Daly, et al.
Published: (2022-12-01)